Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics
- PMID: 38223007
- PMCID: PMC10784448
- DOI: 10.1007/s12291-023-01130-7
Molecular Mechanisms in the Etiology of Polycystic Ovary Syndrome (PCOS): A Multifaceted Hypothesis Towards the Disease with Potential Therapeutics
Abstract
Among the premenopausal women, Polycystic Ovary Syndrome (PCOS) is the most prevalent endocrinopathy affecting the reproductive system and metabolic rhythms leading to disrupted menstrual cycle. Being heterogeneous in nature it is characterized by complex symptomology of oligomennorhoea, excess of androgens triggering masculine phenotypic appearance and/or multiple follicular ovaries. The etiology of this complex disorder remains somewhat doubtful and the researchers hypothesize multisystem links in the pathogenesis of this disease. In this review, we attempt to present several hypotheses that tend to contribute to the etiology of PCOS. Metabolic inflexibility, aberrant pattern of gonadotropin signaling along with the evolutionary, genetic and environmental factors have been discussed. Considered a lifelong endocrinological implication, no universal treatment is available for PCOS so far however; multiple drug therapy is often advised along with simple life style intervention is mainly advised to manage its cardinal symptoms. Here we aimed to present a summarized view of pathophysiological links of PCOS with potential therapeutic strategies.
Keywords: Environmental toxins; Etiology; Genetics; Neuroendocrine; PCOS; Potential therapeutics.
© The Author(s), under exclusive licence to Association of Clinical Biochemists of India 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Conflict of interest statement
Conflict of interestAuthors declare no conflict of interest.
Figures





Similar articles
-
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.Mol Metab. 2020 May;35:100937. doi: 10.1016/j.molmet.2020.01.001. Epub 2020 Feb 5. Mol Metab. 2020. PMID: 32244180 Free PMC article.
-
A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).J Assist Reprod Genet. 2022 Nov;39(11):2439-2473. doi: 10.1007/s10815-022-02625-7. Epub 2022 Oct 3. J Assist Reprod Genet. 2022. PMID: 36190593 Free PMC article. Review.
-
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC. Endocr Pract. 2015. PMID: 26509855
-
Polycystic ovary syndrome in the Indian Subcontinent.Semin Reprod Med. 2008 Jan;26(1):22-34. doi: 10.1055/s-2007-992921. Semin Reprod Med. 2008. PMID: 18181079 Review.
-
Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.Iran J Basic Med Sci. 2019 Jan;22(1):3-16. doi: 10.22038/ijbms.2018.31776.7646. Iran J Basic Med Sci. 2019. PMID: 30944702 Free PMC article. Review.
Cited by
-
Correlation of Diabetes Related Factors with Vitamin D and Immunological Parameters in T2DM Kashmiri Population.Indian J Clin Biochem. 2024 Oct;39(4):586-592. doi: 10.1007/s12291-023-01144-1. Epub 2023 Jul 28. Indian J Clin Biochem. 2024. PMID: 39346716
-
Competence of Combined Low Dose of Human Chorionic Gonadotropin (HCG) and Clomiphene Citrate (CC) Versus Continued CC during Ovulation Induction in Women with CC-Resistant Polycystic Ovarian Syndrome: A Randomized Controlled Trial.Medicina (Kaunas). 2024 Aug 12;60(8):1300. doi: 10.3390/medicina60081300. Medicina (Kaunas). 2024. PMID: 39202581 Free PMC article. Clinical Trial.
-
Mechanism of elevated LH/FSH ratio in lean PCOS revisited: a path analysis.Sci Rep. 2024 Apr 8;14(1):8229. doi: 10.1038/s41598-024-58064-0. Sci Rep. 2024. PMID: 38589425 Free PMC article.
-
Circadian rhythm disruption and polycystic ovary syndrome: a systematic review and meta-analysis.AJOG Glob Rep. 2025 Mar 20;5(2):100479. doi: 10.1016/j.xagr.2025.100479. eCollection 2025 May. AJOG Glob Rep. 2025. PMID: 40292350 Free PMC article. Review.
-
Effect of Junk Food on Hormonal and Metabolic Manifestations in Polycystic Ovarian Syndrome Phenotypes: A Case-Control Study of Kashmiri Population.Indian J Clin Biochem. 2025 Apr;40(2):218-232. doi: 10.1007/s12291-023-01169-6. Epub 2023 Dec 24. Indian J Clin Biochem. 2025. PMID: 40123636
References
-
- Escobar-Morreale HF. Defining PCOS: A syndrome with an intrinsic heterogeneous nature. Polycystic Ovary Syndrome: Elsevier; 2022. p. 3–13.
-
- Yazdani, A. Polycystic ovarian syndrome. Examination Obstetrics and Gynaecology. 2010:21.
Publication types
LinkOut - more resources
Full Text Sources